Redefining Hormone Sensitive Disease in Advanced Prostate Cancer

by Hou, Xiaoyu, Flaig, Thomas W.
Published 2012

Geriatric considerations in the treatment of advanced prostate cancer

by Kessler, Elizabeth R., Flaig, Thomas W.
Published 2014

miR-125b Regulation of Androgen Receptor Signaling Via Modulation of the Receptor Complex Co-Repressor NCOR2

by Yang, Xiaoping, Bemis, Lynne, Su, Lih-Jen, Gao, Dexiang, Flaig, Thomas W.
Published 2012

Synthesis and Characterization of Dimethylbis(2-pyridyl)borate Nickel(II) Complexes: Unimolecular Square-Planar to Square-Planar Rotation around Nickel(II)

by Celaje, Jeff A., Pennington-Boggio, Megan K., Flaig, Robinson W., Richmond, Michael G., Williams, Travis J.
Published 2014

Treatment evolution for metastatic castration‐resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real‐world data

by Flaig, Thomas W., Potluri, Ravi C., Ng, Yvette, Todd, Mary B., Mehra, Maneesha
Published 2015

Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer

by Goodman, O B, Flaig, T W, Molina, A, Mulders, P F A, Fizazi, K, Suttmann, H, Li, J, Kheoh, T, de Bono, J S, Scher, H I
Published 2014

Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT)

by Altoos, Basel, Amini, Arya, Yacoub, Muthanna, Bourlon, Maria T., Kessler, Elizabeth E., Flaig, Thomas W., Fisher, Christine M., Kavanagh, Brian D., Lam, Elaine T., Karam, Sana D.
Published 2015

Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia

by Yang, Xiaoping, La Rosa, Francisco G., Genova, Elizabeth Erin, Huber, Kendra, Schaack, Jerome, DeGregori, James, Serkova, Natalie J., Li, Yuan, Su, Lih-Jen, Kessler, Elizabeth, Flaig, Thomas W.
Published 2013

Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study

by Bhatia, Shailender, Curti, Brendan, Ernstoff, Marc S, Gordon, Michael, Heath, Elisabeth I, Miller, Wilson H, Puzanov, Igor, Quinn, David I, Flaig, Thomas W, VanVeldhuizen, Peter, Byrnes-Blake, Kelly, Freeman, Jeremy A, Bittner, Rachel, Hunder, Naomi, Souza, Sonia, Thompson, John A
Published 2014

Retrospective Analysis of the Safety and Efficacy of High-dose Interleukin-2 After Prior Tyrosine Kinase Inhibitor Therapy in Patients With Advanced Renal Cell Carcinoma

by Lam, Elaine T., Wong, Michael K. K., Agarwal, Neeraj, Redman, Bruce G., Logan, Theodore, Gao, Dexiang, Flaig, Thomas W., Lewis, Karl, Poust, Jamie, Monk, Paul, Jarkowski, Anthony, Sendilnathan, Arun, Bolden, Marcus, Kuzel, Timothy M., Olencki, Thomas
Published 2014